184 results found.
BARE BONES® - June 15, 1999
COMPUTER MOTION formed a strategic alliance with CONMED for the purpose of integrating its HERMES Control Center with ConMed's next-generation of electrosurgical products. Once development is complete and FDA clearance is received, ConMed will sell HERMES-Ready electrosurgical products and Computer ...
BARE BONES® - June 15, 1999
CONMED’s LINVATEC subsidiary received 510(k) clearance from FDA to market its bioabsorbable Endopearl for enhanced fixation in ACL reconstruction. Studies have shown that use of the device increases the attachment strength of ligament grafts up to 50% over current methods. (ConMed Corporation n...
BARE BONES® - May 15, 1999
CONMED’s subsidiary, LINVATEC, and OSTEOBIOLOGICS signed a joint strategic alliance through which the 2 companies will explore bioabsorbable technologies for the repair of articular cartilage and other musculoskeletal tissues. (ConMed Corporation news release; OsteoBiologics, Inc. news release,...
BARE BONES® - April 15, 1999
CONMED received clearance from FDA to begin marketing the Concept Ablator, a single-use, high frequency electrical energy device to ablate damaged soft tissue. The device is one of a number of new products launched or to be launched by the company and its subsidiaries during 1999. In early March 199...
BARE BONES® - October 15, 1998
INTEGRA LIFESCIENCES entered into collaborative agreements with both ConMed’s LINVATEC subsidiary and BIONX IMPLANTS. Bionx and Linvatec will each have exclusive rights to purchase Integra’s resorbable polymer for use in specifically-permitted applications of their products. Products cover...
BARE BONES® - August 15, 1998
CONMED created a salesforce for Linvatec’s small bone and specialty products lines and established an international sales/distribution network for the Linvatec international business. (ConMed Corporation news release, 7/23/98)
BARE BONES®, AAOS Edition - February 28, 1998
CONMED: argon beam coagulation technology focuses radiofrequency energy into a directional, non-contact, room-temperature beam of argon gas which allows for more rapid coagulation, reduced possibility of rebleeding, reduced OR time, less tissue damage.
ORTHOKNOW® - January 15, 1998
SULZER RAISES THE BAR; CONMED ENTERS. By John A. Engelhardt. Consolidation frenzy continues according to our predictions in past issues of OrthoKnow. The latest two high-level acquisitions indicate trends you’ll likely see more of—“strangers” entering the market and way high va...
BARE BONES® - December 15, 1997
CONMED and Bristol-Myers Squibb signed a stock and asset purchase agreement through which Conmed will pay $370MM in cash to acquire LINVATEC and certain assets relating to Linvatec’s international business and Hall Surgical business. Conmed markets and manufactures electrosurgical systems and i...
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2020 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group